Longevity & AgingBlocking Two Immune Signals Shields Hearts From mRNA Vaccine Myocarditis in Mice
Rare myocarditis after mRNA COVID-19 vaccination, mostly in young males after the second dose, has an unclear cause. Researchers combined published human plasma data, human stem cell-derived macrophages, T cells, cardiomyocytes and cardiac spheroids, and mouse models to look for mediators. They found that the chemokine CXCL10 (made mainly by macrophages) and IFN-γ (made mainly by T cells) rise early after vaccination and are higher in patients with myocarditis. Neutralizing both reduced cardiac injury markers and immune cell infiltration in vaccinated mice without greatly lowering antibody responses. Genistein, a plant-derived phytoestrogen, also reduced injury in cell and mouse models, apparently by dampening immunoproteasome activity. The findings are preclinical and do not yet support clinical use.